Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: AbbVie Pursues Novel Neuropsychiatric Drug Class With Gilgamesh

May 14 2024

• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Deal Watch 2021 — • Source: Shutterstock

Related Content

Keeping Track: US FDA Clears Another CAR-T And Another Novel ADHD Drug; Submissions Blossom

Apr 05 2021

Finance Watch: New Funds Keep Venture Capital Flowing Into Biopharma

Apr 10 2023

Finance Watch: Syndax Has A Standout Post-ASH Offering As Peers Scramble For Cash

Dec 21 2023

Fulcrum’s Losmapimod Improves Multiple Measures, But Not Primary Endpoint

Jun 24 2021

Eiger To Close After GLP-1 Antagonist Gambit Fails

Apr 02 2024

The UK’s Cancer Vaccine Partnership With BioNTech Is Another First – But Can It Deliver?

May 03 2024

Novo Nordisk Foundation Strengthens Ties With Gates

May 06 2024

BridgeBio Spins Out Cancer Arm With $200m Fundraise

May 03 2024

Metagenomi Looks For Upside To Moderna’s Exit

May 02 2024

Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout

May 02 2024

Astellas Stakes Claim In CAR-Ts For Solid Tumors With Poseida Deal

May 01 2024

Deals In Bag, Dr Reddy’s Sharpens Top 5 Targeted Home Run

May 14 2024

Takeda Gets A Try-Before-You-Buy Option In Alzheimer’s Immunotherapy

May 13 2024

Novo Aims To Go Significantly Beyond With Latest Obesity Deal

May 09 2024

Sanofi’s $500m COVID-19 Deal Comes Four Years Too Late

May 10 2024

Maze Finds A Way As Shionogi Signs On To Develop Pompe Drug

May 10 2024

Gossamer Partners With Chiesi To Accelerate Seralutinib Development

May 06 2024

A Visual Trip Through The Psychedelic Pipeline

Mar 09 2024

Xbrane Pulls In US Ranibizumab Partner After FDA Disappointment

May 13 2024

Biocon Strikes Mexican Deal For Liraglutide

May 13 2024

Teva Exits Japanese Generics With Plan To Sell Local Business

May 09 2024

Podcast: Zydus Lifesciences MD On Rare Disease Focus, Outcomes-Based Digital Transformation

Apr 22 2022

Deal Watch: Lilly Finds New Partners For Genetic Disorders, Protein Degradation

Nov 25 2020

Related Companies

AbbVie Inc.

Gilgamesh Pharmaceuticals, Inc.

Fulcrum Therapeutics Inc.

Sanofi

Reneo Pharmaceuticals, Inc.

OnKure Therapeutics, Inc

Eli Lilly and Company

Lantern Pharma, Inc

Eiger BioPharmaceuticals, Inc.

Formosa Pharmaceuticals Inc.

Tabuk Pharmaceutical Manufacturing Co.

Arecor Therapeutics plc

Invion Limited

Arbor Biotechnologies

Sciwind Biosciences Co., Ltd.

HK inno.N Corp.

M8 Pharmaceuticals

Acino International AG

Supernus Pharmaceuticals, Inc.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

BioCopy AG

CSL Limited

CSL Seqirus

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window